Subtopic Deep Dive
Inhaled Biologics
Research Guide
What is Inhaled Biologics?
Inhaled biologics refers to the pulmonary delivery of proteins, peptides, and nucleic acids via aerosolized formulations for systemic or local therapeutic effects.
Researchers focus on spray drying and nanoparticle encapsulation to stabilize biologics against pulmonary degradation (Vehring, 2007; 1598 citations). Key challenges include alveolar absorption and enzymatic barriers (Agu et al., 2001; 400 citations). Over 10 papers in the corpus address formulation strategies like microparticles for insulin and monoclonal antibodies.
Why It Matters
Inhaled biologics enable needle-free systemic delivery, bypassing first-pass metabolism with the lung's 100 m² surface area (Labiris and Dolovich, 2003; 1177 citations). Applications target diabetes via inhaled insulin and oncology with antibody aerosols, improving patient compliance (Agu et al., 2001). Nanoparticles enhance bioavailability but raise toxicity concerns (de Jong and Borm, 2008; 3763 citations). Mansour et al. (2009; 466 citations) highlight direct lung targeting for respiratory diseases.
Key Research Challenges
Biologic Stabilization
Proteins aggregate during aerosolization and face shear forces in inhalers (Vehring, 2007). Spray drying preserves structure but requires excipients like sugars. Lung surfactants destabilize formulations (Labiris and Dolovich, 2003).
Pulmonary Absorption Barriers
Alveolar epithelium limits peptide transport due to mucociliary clearance (Agu et al., 2001). Nanoparticles improve penetration but risk immunogenicity (de Jong and Borm, 2008). Permeability enhancers cause inflammation (Mansour et al., 2009).
Aerosol Formulation Toxicity
Inhaled nanoparticles trigger oxidative stress in lung cells (de Jong and Borm, 2008). Simulated lung fluids test stability but overlook chronic effects (Marques et al., 2011). Device-particle interactions reduce delivery efficiency (Labiris and Dolovich, 2003).
Essential Papers
Drug delivery and nanoparticles: Applications and hazards
de Jong · 2008 · International Journal of Nanomedicine · 3.8K citations
Wim H De Jong1, Paul JA Borm2,31Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; 2Zuyd University, Cen...
Pharmaceutical Particle Engineering via Spray Drying
Reinhard Vehring · 2007 · Pharmaceutical Research · 1.6K citations
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
N. R. Labiris, Myrna Dolovich · 2003 · British Journal of Clinical Pharmacology · 1.2K citations
As the end organ for the treatment of local diseases or as the route of administration for systemic therapies, the lung is a very attractive target for drug delivery. It provides direct access to d...
Simulated Biological Fluids with Possible Application in Dissolution Testing
Margareth Marques, Raimar Löebenberg, May Almukainzi · 2011 · Dissolution Technologies · 1.0K citations
This literature review is a compilation of the composition and, in most cases, the preparation instructions for simulated biological fluids that may be used as dissolution media in the evaluation o...
Intranasal Drug Delivery: How, Why and What for?
Anaísa Pires, Ana Fortuna, Gilberto Alves et al. · 2009 · Journal of Pharmacy & Pharmaceutical Sciences · 613 citations
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a targe...
Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery
Miléna Lengyel, Nikolett Kállai‐Szabó, Vince Antal et al. · 2019 · Scientia Pharmaceutica · 546 citations
Microparticles, microspheres, and microcapsules are widely used constituents of multiparticulate drug delivery systems, offering both therapeutic and technological advantages. Microparticles are ge...
Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review
Per G. Djupesland · 2012 · Drug Delivery and Translational Research · 513 citations
Nasal delivery is the logical choice for topical treatment of local diseases in the nose and paranasal sinuses such as allergic and non-allergic rhinitis and sinusitis. The nose is also considered ...
Reading Guide
Foundational Papers
Start with Labiris and Dolovich (2003; Part I, 1177 citations) for lung physiology, then Vehring (2007; 1598 citations) for particle engineering, and Agu et al. (2001; 400 citations) for biologic-specific barriers.
Recent Advances
Mansour et al. (2009; 466 citations) on nanomedicine advances; Lengyel et al. (2019; 546 citations) on microparticles for biologics.
Core Methods
Spray drying (Vehring, 2007); nanoparticle encapsulation (de Jong and Borm, 2008); simulated lung fluid testing (Marques et al., 2011).
How PapersFlow Helps You Research Inhaled Biologics
Discover & Search
Research Agent uses searchPapers('inhaled biologics spray drying') to find Vehring (2007), then citationGraph reveals 50+ downstream works on protein stabilization, and findSimilarPapers expands to Agu et al. (2001) for absorption models. exaSearch queries 'pulmonary peptide delivery nanoparticles' uncovers Mansour et al. (2009).
Analyze & Verify
Analysis Agent runs readPaperContent on Vehring (2007) to extract spray drying parameters, then verifyResponse with CoVe cross-checks claims against Labiris and Dolovich (2003). runPythonAnalysis simulates dissolution in simulated lung fluids from Marques et al. (2011) using pandas for bioavailability curves. GRADE grading scores evidence strength for nanoparticle safety from de Jong and Borm (2008).
Synthesize & Write
Synthesis Agent detects gaps in chronic toxicity studies via contradiction flagging across de Jong (2008) and Mansour (2009), then Writing Agent uses latexEditText for manuscript sections and latexSyncCitations to integrate 20 references. exportMermaid generates aerosol deposition flowcharts from Labiris data.
Use Cases
"Model inhaled insulin bioavailability from literature data"
Research Agent → searchPapers('inhaled insulin biologics') → Analysis Agent → runPythonAnalysis (pandas fits absorption curves from Agu et al. 2001) → matplotlib plots PK profiles.
"Draft review on spray drying for monoclonal antibodies"
Synthesis Agent → gap detection (Vehring 2007 vs Mansour 2009) → Writing Agent → latexEditText + latexSyncCitations + latexCompile → LaTeX PDF with 15 citations.
"Find code for pulmonary nanoparticle simulation"
Research Agent → paperExtractUrls (de Jong 2008) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis verifies simulation scripts.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'inhaled biologics nanoparticles', structures report with GRADE-scored sections on stabilization (Vehring chain). DeepScan's 7-step analysis verifies toxicity claims in de Jong (2008) with CoVe checkpoints and Python fluid simulations. Theorizer generates hypotheses on enhancer-free absorption from Agu et al. (2001) patterns.
Frequently Asked Questions
What defines inhaled biologics?
Delivery of proteins, peptides, and nucleic acids via lung aerosols for systemic effects, leveraging thin alveolar epithelium (Agu et al., 2001).
What are main formulation methods?
Spray drying engineers particles for stability (Vehring, 2007); nanoparticles via encapsulation avoid aggregation (Mansour et al., 2009).
What are key papers?
de Jong and Borm (2008; 3763 citations) on nanoparticle hazards; Vehring (2007; 1598 citations) on spray drying; Agu et al. (2001; 400 citations) on lung delivery.
What open problems exist?
Chronic immunogenicity of inhaled antibodies; scalable stabilization without toxicity (de Jong and Borm, 2008); poor peptide bioavailability beyond insulin (Agu et al., 2001).
Research Inhalation and Respiratory Drug Delivery with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Inhaled Biologics with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers